AMG 509 (Xaluritamig), an Anti-STEAP1 XmAb 2+1 T-cell Redirecting Immune Therapy with Avidity-Dependent Activity against Prostate Cancer.

已完结 20 由钱钱发布于 2026/7/9 8:19:13

DOI:10.1158/2159-8290.CD-23-0984
作者：Olivier Nolan-Stevaux, Cong Li, Lingming Liang, Jinghui Zhan, Juan Estrada, Tao Osgood, Fei Li, Hanzhi Zhang, Ryan Case, Christopher M Murawsky, Bram
文献类型：期刊论文
补充材料：只需要正文

American Association for Cancer Research (AACR)

Abstract：The tumor-associated antigen STEAP1 is a potential therapeutic target that is expressed in most prostate tumors and at increased levels in metastatic castration-resistant prostate cancer (mC

应助信息

19小时前

墩墩李

4368b5377b2c11f1bb6b34735aa3bc31.zip 已采纳

19小时前

Book学术机器人

2026/7/9 8:19:13 未找到该文献，机器人已退出，请等待人工下载

2026/7/9 8:19:13 Book学术AI机器人收到请求，开始寻找文献

2026/7/9 8:19:13 已向机器人发送请求

19小时前

钱钱发布求助

上一个求助:其它数据库Naturally Fractured Carbonate Reservoir Characterization: A Case Study of a Mature High-Pour Point Oil Field in Hungary 下一个求助:其它数据库Effectiveness of Baricitinib on Nail Alopecia Areata: A 48-Week Single-Center Retrospective Study.